Campbell & CO Investment Adviser LLC Boosts Stock Position in Phibro Animal Health Corporation $PAHC

Campbell & CO Investment Adviser LLC increased its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 14.1% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 48,409 shares of the company’s stock after buying an additional 5,987 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in Phibro Animal Health were worth $1,236,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Phibro Animal Health by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock worth $260,000 after acquiring an additional 546 shares during the last quarter. Prospera Financial Services Inc boosted its position in shares of Phibro Animal Health by 3.6% during the 2nd quarter. Prospera Financial Services Inc now owns 19,910 shares of the company’s stock valued at $508,000 after acquiring an additional 690 shares during the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Phibro Animal Health by 7.6% in the second quarter. State of Alaska Department of Revenue now owns 12,129 shares of the company’s stock valued at $309,000 after purchasing an additional 859 shares during the period. Bank of New York Mellon Corp increased its position in Phibro Animal Health by 0.3% during the second quarter. Bank of New York Mellon Corp now owns 268,877 shares of the company’s stock worth $6,867,000 after purchasing an additional 906 shares during the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its position in Phibro Animal Health by 10.0% in the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,530 shares of the company’s stock worth $294,000 after acquiring an additional 1,044 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

Phibro Animal Health stock opened at $45.33 on Wednesday. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $46.42. The firm has a market cap of $1.84 billion, a PE ratio of 38.42, a price-to-earnings-growth ratio of 1.24 and a beta of 0.81. The company’s 50 day moving average is $40.06 and its two-hundred day moving average is $31.43.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.58 by $0.15. The business had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, research analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 26th. This represents a $0.48 annualized dividend and a yield of 1.1%. Phibro Animal Health’s dividend payout ratio is 28.92%.

Insider Transactions at Phibro Animal Health

In other news, CEO Jack Bendheim sold 38,303 shares of Phibro Animal Health stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87. Following the completion of the transaction, the chief executive officer owned 20,577 shares in the company, valued at approximately $931,932.33. This trade represents a 65.05% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders sold 109,159 shares of company stock valued at $4,620,198. 50.13% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on PAHC shares. Weiss Ratings upgraded Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, November 5th. Zacks Research upgraded shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Monday, September 29th. Bank of America upped their target price on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research report on Friday, August 29th. JPMorgan Chase & Co. lifted their price target on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. Finally, Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $31.40.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.